Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation
Kimman, T., Cuenca, M., Tieland, R. G., Rockx-Brouwer, D., Janssen, J., Motais, B., Slomp, A., Pleijte, C., Heijhuurs, S., Meringa, A. D., Boschloo, W., Bosma, D. M. T., Kroos, S., Lo Presti, V., Sluijter, J. P. G., Nierkens, S., Bovenschen, N., Kuball, J., van Mil, A. & Minnema, M. C. & 2 others, , 13 Apr 2026, In: Nature Communications. 17, 1, 3442.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation
Kimman, T., Cuenca, M., Tieland, R. G., Rockx-Brouwer, D., Janssen, J., Motais, B., Slomp, A., Pleijte, C., Heijhuurs, S., Meringa, A. D., Boschloo, W., Bosma, D. M., Kroos, S., Lo Presti, V., Sluijter, J. P. G., Nierkens, S., Bovenschen, N., Kuball, J., van Mil, A. & Minnema, M. C. & 2 others, , 19 May 2025, In: Nature Communications. 16, 1, 12 p., 4638.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile58 Downloads (Pure) -
Impact of 3D cell culture hydrogels derived from basement membrane extracts or nanofibrillar cellulose on CAR-T cell activation
Revilla, S. A., Cutilli, A., Cambiaso, E., Rockx-Brouwer, D., Frederiks, C. L., Falandt, M., Levato, R., Kranenburg, O., Lindemans, C. A., Coffer, P. J., Peperzak, V., Mocholi, E. & Cuenca, M., 19 Sept 2025, In: iScience. 28, 9, 17 p., 113234.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
Bridging the gap between scientific discoveries and clinical application at the Utrecht Science Park
Peperzak, V. & Coquet, J. M., Apr 2024, In: Immunology and Cell Biology. 102, 4, p. 232-234 3 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient-derived in vitro model
van Nieuwenhuijzen, N., Cuenca, M., Abbink, L., Jak, M., Peperzak, V. & Minnema, M. C., Feb 2024, In: EJHaem. 5, 1, p. 141-146 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure)
Prizes
-
Dutch Cancer Society/KWF personal Bas Mulder Award: Towards therapeutic targeting of Myeloid cell leukemia 1 (MCL-1) in B cell cancers.
Peperzak, V. (Recipient), 2015
Prize: Fellowship awarded competitively
-
Dutch Cancer Society/KWF Research Project: Personalized strategy to avert drug resistance in hematologic cancers.
Peperzak, V. (Recipient), Minnema, M. (Recipient) & Jak, M. (Recipient), 2017
Prize: Fellowship awarded competitively
-
Dutch Cancer Society/KWF Unique High Risk Project: Empowering the T cell killing machinery to eradicate cancer cells and prevent outgrowth.
Peperzak, V. (Recipient) & Sebestyen, Z. (Recipient), 2018
Prize: Fellowship awarded competitively
-
-
KWF/Alpe d'HuZes Research Project grant: Optimized Killing (OK) technology to empower engineered T or NK cells in the treatment of cancer.
Peperzak, V. (Recipient) & Sebestyen, Z. (Recipient), 2020
Prize: Fellowship awarded competitively
Press/Media
-
BREAKING: Bestuur Lymph&Co "adopteert" nieuw baanbrekend onderzoek naar vaccins voor lymfklierkanker bij volwassenen én kinderen.
Boes, M., Peperzak, V. & Meyer Wentrup, F.
15/03/19
1 Media contribution
Press/Media: Public Engagement Activities